PharmaShots | Incisive News in 3 Shots

Subscribe Now

MHLW Approval

AstraZeneca's Forxiga (dapagliflozin) Receives MHLW's Approval for the Treatment of Chronic Kidney Disease in Patients with and without T2D

AstraZeneca's Forxiga (dapagliflozin) Receives MHLW's Approval for the Treatment of Chronic Kidney Disease in Patients with and wi...

August 26, 2021

Contact Us

First Floor, B-66, Sector 63 Noida, Uttar Pradesh, INDIA - 201301
+91-120 428 0707
connect@pharmashots.com
Newsletter

Our Information

Follow Us